Startup vendor FIRE1 completed patient enrollment in its U.S. early feasibility study for a heart failure remote monitoring device that directly measures fluid volume inside the IVC.

The Ornish diet, a plant-based option developed to help prevent heart disease, also made the final ranking. 

Black patients are already less likely to receive LVADs or transplants compared to whites, and these inaccurate readings can further widen the disparities.

Reprieve Cardiovascular emerged from stealth mode this week with sizable financial backing and some big name board members to advance development for its intelligent, automated diuretic and fluid management system for heart failure.

Researchers explored data from nearly 17,000 U.S. heart transplant candidates, developing an updated model that ranks patients based on their mortality risk. 

New Jersey-based Impulse Dynamics says it will use the new financing to fund clinical research and continue developing advanced heart failure devices. 

Scot Pollard has a long family history of heart disease, and he’s been on a watch list for several years now due to his size. He's been in and out of hospitals for more than three years due to an ongoing fight with cardiomyopathy. 

Francisco Arabia, MD, spoke with Cardiovascular Business about the present and future of total artificial heart technology.